Have Sol-Gel Technologies insiders bought shares recently?

No open-market purchase by an insider of Sol-Gel Technologies is on record in SEC filings since 2006.

Who is selling Sol-Gel Technologies stock?

No open-market sale by an insider of Sol-Gel Technologies (SLGL) was filed with the SEC in the last 90 days.

Do members of Congress trade SLGL?

No trade in Sol-Gel Technologies (SLGL) was disclosed by a member of Congress in the last 12 months.

When does Sol-Gel Technologies report its next results?

Sol-Gel Technologies's next results are expected on Nov 18, 2026. The date can move until the company confirms it. Insiders often trade in the weeks right after results.

Where does this data come from?

From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.

Sol-Gel Technologies (SLGL) insider trading and stock trades

OQRO

Ask OQRO about this page

Ask

Want the short version?

Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.

Explain this page What did insiders at SLGL buy and sell in the last 90 days?Which members of Congress and which funds traded SLGL recently?

Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.

SLGL price and disclosed activity

+54.9% (+$19.54) from Nov 13, 2025 to Nov 13, 2026 · adjusted daily closes

No disclosed open-market insider trades, politician trades or fund 13F changes in this period.

Insider and Congress marks sit on the trade date stated in the filing; solid is a purchase, hollow a sale. A number means several trades too close to tell apart at this range: pick a shorter range or open it for the list. Congress amounts are official ranges; mark size uses the lower bound. Past moves are not a forecast.

Insider open-market trades, filed in the last 90 daysNoneFew or no Form 4 filings, see the note belowInsider trades →Congress trades, disclosed in the last 90 daysNoneNo House or Senate report names this stockCongress →Fund 13F changes, last 12 monthsNoneNo followed fund reported a changeFund moves →Federal contracts starting in the last 12 monthsNoneNo award found for this companyContracts →

Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.

Pharmaceutical Preparations company based in Ness Ziona. Foreign private issuer: reports on Form 20-F or 40-F. Its directors and officers file insider-trading forms (Form 4) only since 18 March 2026.

Last 12 months

+54.9%

S&P 500 +12.3% over the same dates

Market value

$154M

Close of Nov 13, 2026 × shares outstanding (per ADS where it applies)

S&P 500 +12.3% over the same dates. Prices adjusted for splits and dividends.

Short interest: 135K shares sold short (4.8% of shares outstanding), −0.9% vs the previous count, 3.2 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.

When insiders usually buy

Last results

—

Next results, expected

Nov 18, 2026

Purchases after results

Not enough history

From Sol-Gel Technologies's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Sol-Gel Technologies's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.

Company size

20-F filed Mar 19, 2026

Revenue, fiscal 2025

$19.4M

+68.0% vs the year before

Net income, fiscal 2025

−$6.13M

A loss for the year

Shares outstanding

2.79M

As of Dec 31, 2025

Holders above 5%

Anyone owning more than 5% must file within days. Structured filings have existed since December 2024, so older stakes that were never amended may be missing.

Latest

See everything

Fund moves

13G stake

5.1%Stake

Filed 3w ago

A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.

More Official record

Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.

Want the short version?

Sol-Gel Technologies

How this filing works

Questions about Sol-Gel Technologies insider trading

Other Pharmaceutical Preparations companies

SLGL price and disclosed activity

When insiders usually buy

Company size

Holders above 5%

Latest

5.1%Stake

When insiders usually buy

Holders above 5%